2024 Impact Factor: 1.6
2024 CiteScore: 2.5
pISSN: 2251-6085
eISSN: 2251-6093
Chairman & Editor-in-Chief:
Dariush D. Farhud, MD, Ph.D., MG.

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE). 

Note: Because of some problems in website, If a problem occurs in the third step (metadata), please do not fill the reference box and put only a dot in the abstract box.
Submitted manuscript, should embrace the following criteria:
Types of Manuscripts
Original articles:
These include randomized controlled trials, intervention studies, studies of screening and diagnostic test, outcome studies, and cost-effectiveness analyses. The text of original articles amounting to utmost 3000 words (excluding Abstract, References and Tables) should include Title; the Abstract; Introduction; Materials & Methods; Results; Discussion; Conclusion; Acknowledgement; References, Tables and Figures (Not more than 4500 words).
Review Articles:
They should be written by authors considered experts on the subject. Therefore, the corresponding author of the review article must be one of the authors of at least three articles presented in Reference section. Systematic reviews and meta-analysis are more welcomed and they should respectively follow the PRISMA (http://www.prisma-statement.org/) and MOOSE guidelines (http://www.consort-statement.org). Review articles must include an abstract of no more than 250 words, a main text between 2000-3000 words excluding up to 90 references, and up to 6 tables and/or figures (altogether 5500-6000 words).
Short Communications:
Short communications are brief reports of research works containing new findings, which are not exceeding 2500 words from introduction through references. The Short Communication consists of Abstract, main body including Introduction, Methods, Results, Discussion, Conclusion; Acknowledgement, References, Tables and Figures (Not more than 3000 words).
Case reports:
Case reports are accepted provided they are of exceptional interest for readers. The case report consists of Abstract (unstructured), Introduction, Case Report, Discussion, Acknowledgements, and References. Case reports must not exceed 1,000 words, 15 references and a reasonable amount of tables and/or figures (Not more than 2500 words).
Letters to the Editor:
Letters could be of two types, commenting either on recently published articles or reporting cases, outbreaks, or original research. The former must be received within 2 months of publication of the article to which they refer and should be no longer than 500 words. The latter should contain no more than 1000 words altogether including up to 10 references and 2 figures and/or tables. They should not be divided into sections.
Other:
Guest Editorial is solicited by the Editorial Board. National Reports or similar cases are accepted based on confirmation by Editorial Board.
Publication Fee:
According to new policy imposed by the journal administration, from now (10 Nov 2015) corresponding authors are requested to pay the publication charge as mentioned below:
|
Article Type |
For Iranian ( RLs) |
For foreigner ($ US) |
|
Review articles, Country Reports |
9000000 |
350 |
|
Original article |
9000000 |
300 |
|
Short Communication |
6000000 |
200 |
|
Case Report |
3000000 |
200 |
|
Letter to the Editor |
2000000 |
150 |
For any specific enquiry, please contact the journal via Email.
Saving account for Iranian authors:
انجمن علمی بهداشت ایران،
بانک ملی، شماره حساب : 0108589984006
IR75 0170 0000 0010 8589 9840 06 شناسه شبا حساب:
Card number: 6037991899637981
For foreign authors details are conveyed via Email.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
The Editorial Board of the journal, reserves the right to accept or reject the article in any stage and any time or delete a part of the text, tables or figures, if necessary.
Important Note: After approving the galley proof by the Corresponding Author, no changes would be accepted at all, especially changing the name of authors or changing the affiliations. The whole responsibility in this case, would be on the authors' side.
2024 Impact Factor: 1.6
2024 CiteScore: 2.5
pISSN: 2251-6085
eISSN: 2251-6093
Chairman & Editor-in-Chief:
Dariush D. Farhud, MD, Ph.D., MG.

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE). 

![]() |
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |